Hemp Therapies Wiki / Liposomal Delivery Systems

Liposomal Glutathione

Liposomal glutathione is formulated specifically to address plain glutathione’s well-documented absorption problem when taken orally.

Why Plain Oral Glutathione Absorbs Poorly

Plain, non-formulated glutathione taken orally is not considered a viable delivery route by some researchers, since it is not well absorbed after oral ingestion in humans. In animal (rat) research cited in the literature, plain glutathione showed zero measurable removal of toxins from the body, compared with meaningfully greater toxin removal from a liposomal glutathione formulation tested under the same conditions. Liposomes are described as protecting their payload from the harsh acidic environment of the stomach during transit, then allowing absorption further down the digestive tract through mechanisms available to lipid-bilayer particles.

Reported Uptake and Plasma-Concentration Differences

One study reported liposomal glutathione producing approximately 1.9-fold higher cellular uptake than plain glutathione, with uptake peaking at around 6 hours. That same research reported liposomal glutathione reaching a maximum plasma concentration of approximately 1,800 ng/mL, described as roughly 6 times higher than the plasma concentration achieved with plain glutathione. In a separate reported comparison, liposomal glutathione produced blood levels roughly 20 times higher on average than a standard glutathione powder, with the standard powder showing no measurable change in blood levels; the same comparison reported a 22% higher baseline blood level after supplementation with the liposomal form.

Published Dose Ranges in Pilot Studies

A one-month pilot clinical study of oral liposomal glutathione administered two dose levels — 500 mg and 1,000 mg per day — in healthy adults, and reported increases in body glutathione stores and in markers associated with immune function. A separate study testing 750 mg of liposomal glutathione taken twice daily for 30 days reported no adverse effects among participants. In that same 30-day study, blood mercury levels decreased by an average of 39% over the study period, with an average 8% reduction observed within the first week; five of seven subjects showed a 19–60% reduction in blood mercury levels, and liver marker (bilirubin) and kidney marker (creatinine) readings were reported as improved in three of four participants tested for each. That 30-day study disclosed a manufacturer affiliation for its authors — one held an ownership stake in the liposomal glutathione product tested, another was an employee of the manufacturer — a relevant caveat when weighing the strength of that data set against independently authored research.

Product Format

Glutathione is sold in liposomal liquid form by multiple supplement brands, commonly dosed around 500 mg per serving; a common liquid serving size is just under one teaspoon (about 4 mL). Some glutathione formulations are labeled for evening use, distinct from timing guidance given for other liposomal ingredients.

Summary

Liposomal glutathione is studied specifically because plain oral glutathione absorbs poorly; the available research reports meaningfully higher uptake and plasma levels for the liposomal form, though one of the most detailed pilot studies discloses a manufacturer affiliation worth weighing alongside its results.